Edition:
United States

Atossa Genetics Inc (ATOS.OQ)

ATOS.OQ on NASDAQ Stock Exchange Capital Market

0.45USD
26 May 2017
Change (% chg)

$-0.02 (-4.26%)
Prev Close
$0.47
Open
$0.46
Day's High
$0.55
Day's Low
$0.44
Volume
74,393
Avg. Vol
36,638
52-wk High
$5.62
52-wk Low
$0.40

Latest Key Developments (Source: Significant Developments)

Atossa Genetics qtrly loss per basic common share $0.45
Thursday, 11 May 2017 05:31pm EDT 

May 11 (Reuters) - Atossa Genetics Inc ::Qtrly loss per basic common share $0.45."we are in the research and development phase and do not generate revenue".Plans to commence a phase 2 clinical study of endoxifen in second half of 2017.  Full Article

Atossa Genetics says second positive interim review on Phase 1 study of endoxifen may advance to final topical dosing level
Wednesday, 10 May 2017 08:00am EDT 

May 10 (Reuters) - Atossa Genetics Inc :Atossa Genetics - second positive interim review on Phase 1 study of endoxifen from independent safety committee who concluded study may advance to final topical dosing level.  Full Article

Atossa Genetics receives approval from institutional review board for continuation of its fulvestrant microcatheter phase 2 study
Tuesday, 9 May 2017 08:00am EDT 

May 9 (Reuters) - Atossa Genetics Inc : :Atossa Genetics receives approval from institutional review board for continuation of its fulvestrant microcatheter phase 2 study.Atossa Genetics - institutional review board associated with montefiore medical center approved fulvestrant microcatheter phase 2 study.  Full Article

Atossa receives positive interim review from safety committee in Endoxifen study
Thursday, 20 Apr 2017 08:15am EDT 

April 20 (Reuters) - Atossa Genetics Inc ::Atossa Genetics receives positive interim review from independent safety committee in phase 1 Endoxifen dose escalation study.Atossa Genetics- independent safety committee reviewed blinded data from first cohort of study, concluded that study may advance to next dosing level.  Full Article

Atossa Genetics now sees public offering of up to 1.0 mln class A units
Tuesday, 28 Mar 2017 12:23pm EDT 

Atossa Genetics Inc : Now sees public offering of up to 1.0 million class a units consisting common stock and warrants - sec filing . In addition, files for 4,000 class b units consisting of series a convertible preferred stock and warrants .Atossa genetics - had previously filed for offering of up to 4 million units consisting of one common share and one warrant for 0.5 shares of common stock.  Full Article

Atossa Genetics files for public offering of up to 4 mln units
Thursday, 23 Mar 2017 06:30am EDT 

Atossa Genetics Inc : Atossa Genetics - files for public offering of up to 4 million units . Atossa Genetics - each unit consists of one share of co's common stock and one warrant for 0.5 shares of common stock .Atossa Genetics - had previously filed for offering of up to 3.5 million units.  Full Article

Atossa Genetics amends qtrly loss to $0.04/shr in Form 10-Q amendment for qtr ended June 30, 2016
Tuesday, 21 Mar 2017 06:53am EDT 

Atossa Genetics Inc : Atossa Genetics Inc - amendment no. 1 to quarterly report on Form 10-Q amends company's quarterly report on Form 10-Q for quarter ended June 30, 2016 .Atossa Genetics-incorrectly stated in 10-Q the loss per common share for three months ended June 30, 2016 as $0.05 rather than correct amount of $0.04.  Full Article

Atossa prices underwritten public offering of 1,150,000 common shares
Wednesday, 31 Aug 2016 06:30am EDT 

Atossa Genetics Inc : Atossa genetics, inc. Prices underwritten public offering of 1,150,000 common shares .Says public offering of 1.15 million common shares priced at $2.50per share.  Full Article

Atossa Genetics announces proposed public offering of common stock
Tuesday, 30 Aug 2016 04:01pm EDT 

Atossa Genetics Inc : Announces proposed public offering of common stock .Intends to use proceeds for working capital and to fund other general corporate purposes, including funding costs of clinical trials.  Full Article

Atossa Genetics says announced a reverse split of its common stock at a ratio of 1-for-15
Thursday, 25 Aug 2016 12:00pm EDT 

Atossa Genetics Inc : Atossa Genetics announces reverse stock split . Says announced a reverse split of its common stock at a ratio of 1-for-15, effective August 26, 2016 .Number of outstanding common shares will be reduced from approximately 39.57 million shares to approximately 2.67 million shares.  Full Article

More From Around the Web

BRIEF-Atossa Genetics qtrly loss per share $0.45

* Atossa Genetics announces first quarter 2017 financial results and provides company update